FluoSphera
FluoSphera develops a multi-organoid technology platform that uses encapsulated human microtissues to mimic systemic communications and physiological responses. The system enables pharmaceutical companies to perform high-throughput screening and multiplexed selectivity assays to predict clinical drug outcomes. Its products, such as FluoSelect and FluoScore, identify selective therapies and therapeutic indices before clinical trials.
Visit websitePlan-les-Ouates, Switzerland
Healthtech
Biotechnology
Drug Discovery
Funding summary
- Total raised
- €2.2M
- Funding rounds
- 2
Investors in FluoSphera
Investors on record for FluoSphera. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like FluoSphera?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors